March 24, 2024
Loading...
You are here:  Home  >  Regions  >  East Ventura County  -  Page 103
Latest

Amgen partnering to develop new drugs

By   /  Friday, July 21st, 2017  /  East Ventura County, Health Care & Life Science, Latest news, Tri-County Public Companies  /  Comments Off on Amgen partnering to develop new drugs

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Conejo Valley biotech scene heats up with Sienna IPO

By   /  Friday, July 14th, 2017  /  East Ventura County, Health Care & Life Science, Latest news, Technology  /  Comments Off on Conejo Valley biotech scene heats up with Sienna IPO

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen’s Kyprolis found to increase cancer survival rate

By   /  Thursday, July 13th, 2017  /  East Ventura County, Health Care & Life Science, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen’s Kyprolis found to increase cancer survival rate

A Phase 3 clinical study of Amgen’s multiple myeloma drug Kyprolis showed that it increased overall survival rate when paired with lenalidomide and dexamethasone versus just those two drugs alone. The drug reduced the risk of death by 21 percent, and patients lived 7.9 months longer when on a regimen that included Kyprolis than those Read More →

Latest

FDA gives full approval to Amgen leukemia drug Blincyto

By   /  Tuesday, July 11th, 2017  /  East Ventura County, Health Care & Life Science, Latest news  /  Comments Off on FDA gives full approval to Amgen leukemia drug Blincyto

Amgen’s leukemia drug Blincyto received full approval from the U.S. Food and Drug Administration on July 11 to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia in adults and children. The biotech giant, headquartered in Thousand Oaks, had previously announced that the drug had been fast-tracked for priority review. The full approval includes data Read More →

Latest

Dubroff: Museum of Ventura County deserves to be preserved

By   /  Friday, July 7th, 2017  /  Columns, East Ventura County, Latest news, West Ventura County  /  Comments Off on Dubroff: Museum of Ventura County deserves to be preserved

Henry Dubroff

Just a year ago, the city of Ventura was celebrating its 150th anniversary with a lot of fanfare and one heck of a party. Now, with one of its iconic cultural institutions in need of help, city officials and Ventura County’s board of supervisors will have to weigh the long-term benefits of putting the Museum Read More →

Latest

Sienna Biopharmaceuticals files for $75 million IPO

By   /  Thursday, July 6th, 2017  /  East Ventura County, Health Care & Life Science, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Sienna Biopharmaceuticals files for $75 million IPO

Westlake Village biotechnology company Sienna Biopharmaceuticals filed for an initial public offering with the Securities and Exchange Commission on June 3, stating expectations to raise up to $74.75 million. Founded in 2010, the company develops clinical-stage topical therapies for inflammatory skin diseases and other conditions. ARCH Venture Partners and Venvest Capital led a $40 million Read More →

Latest

MannKind hires financial adviser after boosting cash on hand

By   /  Thursday, June 29th, 2017  /  East Ventura County, Health Care & Life Science, Latest news, Technology, Tri-County Public Companies  /  Comments Off on MannKind hires financial adviser after boosting cash on hand

MannKind, a Southern California biotechnology company heading to Westlake Village, hired Greenhill & Co. as a financial and strategic adviser June 28, after requesting the last of its line of credit through a loan from the Mann Group. The company will draw on the remaining $30.1 million of funding, using $10.6 million to capitalize unpaid Read More →